DrugPatentWatch Database Preview
VASOSTRICT Drug Profile
When do Vasostrict patents expire, and when can generic versions of Vasostrict launch?
Vasostrict is a drug marketed by Par Sterile Products and is included in one NDA. There are six patents protecting this drug and one Paragraph IV challenge.
The generic ingredient in VASOSTRICT is vasopressin. There are nine drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the vasopressin profile page.
Summary for VASOSTRICT
Generic Entry Opportunity Date for VASOSTRICT
Generic Entry Date for VASOSTRICT*:
Constraining patent/regulatory exclusivity:
NDA:
Dosage:
SOLUTION;IV (INFUSION) |
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Recent Clinical Trials for VASOSTRICT
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Advocate Health Care | N/A |
Recent Litigation for VASOSTRICT
Identify potential future generic entrants
District Court Litigation
| Case Name | Date |
|---|---|
| Par Pharmaceutical, Inc. v. Amneal Pharmaceuticals Company GmbH | 2019-04-18 |
| Par Pharmaceutical, Inc. v. Amphastar Pharmaceuticals, Inc. | 2018-12-20 |
| PAR PHARMACEUTICAL, INC. v. SANDOZ INC. | 2018-10-11 |
Synonyms for VASOSTRICT
| 11034-16-5 |
| 12678-42-1 |
| 196116-EP2272972A1 |
| 196116-EP2272973A1 |
| 196116-EP2277872A1 |
| ADH (hormone) |
| D00101 |
| EINECS 234-236-2 |
| HSDB 3412 |
| Intertocin |
| Inyectable de vasopresina [INN-Spanish] |
| LS-161408 |
| Pitressin (TN) |
| Pituitrin |
| Pituitrin P |
| SCHEMBL1172390 |
| Solute injectable de vasopressine [INN-French] |
| Tonephin |
| UNII-Y87Y826H08 |
| Vasopressin (JP17/USP) |
| Vasopressin, unspecified |
| Vasopressina |
| Vasopressina [DCIT] |
| Vasopressine |
| Vasopressini injectio [INN-Latin] |
| Vasopressins |
| Vasopressinum |
| Y87Y826H08 |
US Patents and Regulatory Information for VASOSTRICT
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Par Sterile Products | VASOSTRICT | vasopressin | SOLUTION;INTRAVENOUS | 204485-001 | Apr 17, 2014 | RX | Yes | Yes | See Pricing | See Pricing | See Pricing | ||||
| Par Sterile Products | VASOSTRICT | vasopressin | SOLUTION;INTRAVENOUS | 204485-002 | Dec 17, 2016 | RX | Yes | Yes | See Pricing | See Pricing | See Pricing | ||||
| Par Sterile Products | VASOSTRICT | vasopressin | SOLUTION;INTRAVENOUS | 204485-001 | Apr 17, 2014 | RX | Yes | Yes | See Pricing | See Pricing | See Pricing | ||||
| Par Sterile Products | VASOSTRICT | vasopressin | SOLUTION;INTRAVENOUS | 204485-002 | Dec 17, 2016 | RX | Yes | Yes | See Pricing | See Pricing | See Pricing | ||||
| Par Sterile Products | VASOSTRICT | vasopressin | SOLUTION;INTRAVENOUS | 204485-001 | Apr 17, 2014 | RX | Yes | Yes | See Pricing | See Pricing | See Pricing | ||||
| Par Sterile Products | VASOSTRICT | vasopressin | SOLUTION;INTRAVENOUS | 204485-001 | Apr 17, 2014 | RX | Yes | Yes | See Pricing | See Pricing | See Pricing | ||||
| Par Sterile Products | VASOSTRICT | vasopressin | SOLUTION;INTRAVENOUS | 204485-002 | Dec 17, 2016 | RX | Yes | Yes | See Pricing | See Pricing | See Pricing | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for VASOSTRICT
| Drugname | Dosage | Strength | RLD | Date |
|---|---|---|---|---|
| ➤ Subscribe | Injection | 20 units/mL, 1 mL | ➤ Subscribe | See Pricing |
